nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—FKBP1A—TGF-beta Receptor Signaling—ZEB2—refractive error	0.0731	0.0731	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—RNF111—refractive error	0.0658	0.0658	CbGpPWpGaD
Everolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—RNF111—refractive error	0.0519	0.0519	CbGpPWpGaD
Everolimus—MTOR—Alpha 6 Beta 4 signaling pathway—LAMA2—refractive error	0.0393	0.0393	CbGpPWpGaD
Everolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—GJD2—refractive error	0.0374	0.0374	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—PML—refractive error	0.0358	0.0358	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—PTPRR—refractive error	0.0325	0.0325	CbGpPWpGaD
Everolimus—MTOR—CDC42 signaling events—RASGRF1—refractive error	0.0284	0.0284	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—AXL—refractive error	0.026	0.026	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—AXL—refractive error	0.0245	0.0245	CbGpPWpGaD
Everolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1D—refractive error	0.0237	0.0237	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—COL2A1—refractive error	0.0216	0.0216	CbGpPWpGaD
Everolimus—MTOR—mTOR signaling pathway—PML—refractive error	0.0167	0.0167	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—RASGRF1—refractive error	0.0159	0.0159	CbGpPWpGaD
Everolimus—MTOR—CDC42 signaling events—PAX6—refractive error	0.0148	0.0148	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PML—refractive error	0.0127	0.0127	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—BMP2—refractive error	0.011	0.011	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	0.0104	0.0104	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—COL9A1—refractive error	0.0103	0.0103	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—refractive error	0.0102	0.0102	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—PML—refractive error	0.00859	0.00859	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—BMP2—refractive error	0.00851	0.00851	CbGpPWpGaD
Everolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PDGFRA—refractive error	0.00802	0.00802	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GREM2—refractive error	0.00787	0.00787	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	0.00753	0.00753	CbGpPWpGaD
Everolimus—FKBP1A—Disease—DSE—refractive error	0.00724	0.00724	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—PDGFRA—refractive error	0.00723	0.00723	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—PDGFRA—refractive error	0.00705	0.00705	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—PDGFRA—refractive error	0.007	0.007	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PDGFRA—refractive error	0.00684	0.00684	CbGpPWpGaD
Everolimus—FKBP1A—Disease—RDH5—refractive error	0.00681	0.00681	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CHN1—refractive error	0.00669	0.00669	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PCCA—refractive error	0.00646	0.00646	CbGpPWpGaD
Everolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—refractive error	0.00645	0.00645	CbGpPWpGaD
Everolimus—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—refractive error	0.00637	0.00637	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—OR2M7—refractive error	0.00597	0.00597	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IPO5—refractive error	0.0059	0.0059	CbGpPWpGaD
Everolimus—FKBP1A—Disease—WNT10A—refractive error	0.00549	0.00549	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—PDGFRA—refractive error	0.0054	0.0054	CbGpPWpGaD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—refractive error	0.00523	0.00523	CbGpPWpGaD
Everolimus—MTOR—Immune System—IFITM2—refractive error	0.00519	0.00519	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—RNF111—refractive error	0.00518	0.00518	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—PDGFRA—refractive error	0.00517	0.00517	CbGpPWpGaD
Everolimus—FKBP1A—Disease—RNF111—refractive error	0.00516	0.00516	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—PDGFRA—refractive error	0.00509	0.00509	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—VIPR2—refractive error	0.00507	0.00507	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—PDGFRA—refractive error	0.00486	0.00486	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—PDGFRA—refractive error	0.00483	0.00483	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—PDGFRA—refractive error	0.00481	0.00481	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—PDGFRA—refractive error	0.00479	0.00479	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RDH5—refractive error	0.00477	0.00477	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PDGFRA—refractive error	0.00472	0.00472	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AXL—refractive error	0.00452	0.00452	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—PDGFRA—refractive error	0.0045	0.0045	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PDGFRA—refractive error	0.0045	0.0045	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—PDGFRA—refractive error	0.0045	0.0045	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LUM—refractive error	0.00447	0.00447	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—PDGFRA—refractive error	0.00446	0.00446	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GREM2—refractive error	0.00443	0.00443	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—PDGFRA—refractive error	0.00442	0.00442	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CTSC—refractive error	0.00441	0.00441	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—PDGFRA—refractive error	0.0044	0.0044	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—PDGFRA—refractive error	0.00417	0.00417	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—VANGL2—refractive error	0.00413	0.00413	CbGpPWpGaD
Everolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—PTEN—refractive error	0.00412	0.00412	CbGpPWpGaD
Everolimus—MTOR—Disease—DSE—refractive error	0.00407	0.00407	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PDGFRA—refractive error	0.00399	0.00399	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	0.00387	0.00387	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—WNT10A—refractive error	0.00384	0.00384	CbGpPWpGaD
Everolimus—MTOR—Disease—RDH5—refractive error	0.00383	0.00383	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CHN1—refractive error	0.00376	0.00376	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—PTEN—refractive error	0.00371	0.00371	CbGpPWpGaD
Everolimus—MTOR—Disease—PCCA—refractive error	0.00363	0.00363	CbGpPWpGaD
Everolimus—MTOR—PI3K/AKT activation—PTEN—refractive error	0.00362	0.00362	CbGpPWpGaD
Everolimus—FKBP1A—Disease—RPS27—refractive error	0.00362	0.00362	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CER1—refractive error	0.00361	0.00361	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RNF111—refractive error	0.00361	0.00361	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TJP2—refractive error	0.00361	0.00361	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—PTEN—refractive error	0.00359	0.00359	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—PTEN—refractive error	0.00351	0.00351	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—refractive error	0.00351	0.00351	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—OR2M7—refractive error	0.00335	0.00335	CbGpPWpGaD
Everolimus—MTOR—Disease—IPO5—refractive error	0.00332	0.00332	CbGpPWpGaD
Everolimus—MTOR—Immune System—RNF111—refractive error	0.00314	0.00314	CbGpPWpGaD
Everolimus—MTOR—Disease—WNT10A—refractive error	0.00309	0.00309	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—PDGFRA—refractive error	0.00307	0.00307	CbGpPWpGaD
Everolimus—MTOR—Disease—RNF111—refractive error	0.0029	0.0029	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VIPR2—refractive error	0.00285	0.00285	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—CYP26A1—refractive error	0.00278	0.00278	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—PTEN—refractive error	0.00277	0.00277	CbGpPWpGaD
Everolimus—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	0.00274	0.00274	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—COL9A1—refractive error	0.00274	0.00274	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RDH5—refractive error	0.00268	0.00268	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTSC—refractive error	0.00267	0.00267	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—PTEN—refractive error	0.00265	0.00265	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—refractive error	0.00263	0.00263	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—PTEN—refractive error	0.00261	0.00261	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AXL—refractive error	0.00254	0.00254	CbGpPWpGaD
Everolimus—MTOR—Disease—LUM—refractive error	0.00252	0.00252	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—PTEN—refractive error	0.00251	0.00251	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—PTEN—refractive error	0.00249	0.00249	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—PTEN—refractive error	0.00248	0.00248	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—refractive error	0.00248	0.00248	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—PTEN—refractive error	0.00247	0.00247	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—PTEN—refractive error	0.00246	0.00246	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—refractive error	0.00242	0.00242	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VANGL2—refractive error	0.00233	0.00233	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—PTEN—refractive error	0.00231	0.00231	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—refractive error	0.00231	0.00231	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—PTEN—refractive error	0.00231	0.00231	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—PTEN—refractive error	0.00229	0.00229	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—PTEN—refractive error	0.00227	0.00227	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—PTEN—refractive error	0.00226	0.00226	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—WNT10A—refractive error	0.00216	0.00216	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—PTEN—refractive error	0.00214	0.00214	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—refractive error	0.00205	0.00205	CbGpPWpGaD
Everolimus—MTOR—Disease—RPS27—refractive error	0.00204	0.00204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RNF111—refractive error	0.00203	0.00203	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CER1—refractive error	0.00203	0.00203	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TJP2—refractive error	0.00203	0.00203	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—BMP2—refractive error	0.00188	0.00188	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PDGFRA—refractive error	0.00175	0.00175	CbGpPWpGaD
Everolimus—MTOR—Immune System—PML—refractive error	0.00171	0.00171	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PDGFRA—refractive error	0.00168	0.00168	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PDGFRA—refractive error	0.00167	0.00167	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—PTEN—refractive error	0.00158	0.00158	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—COL9A1—refractive error	0.00154	0.00154	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EBP—refractive error	0.00119	0.00119	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PDGFRA—refractive error	0.00117	0.00117	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—BMP2—refractive error	0.00106	0.00106	CbGpPWpGaD
Everolimus—MTOR—Immune System—PDGFRA—refractive error	0.00102	0.00102	CbGpPWpGaD
Everolimus—MTOR—Disease—PDGFRA—refractive error	0.000941	0.000941	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DSE—refractive error	0.000905	0.000905	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PTEN—refractive error	0.000898	0.000898	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PTEN—refractive error	0.000863	0.000863	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTEN—refractive error	0.000859	0.000859	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLA2G16—refractive error	0.000807	0.000807	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PCCA—refractive error	0.000807	0.000807	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDGFRA—refractive error	0.000659	0.000659	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTEN—refractive error	0.000601	0.000601	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LUM—refractive error	0.000559	0.000559	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CACNA1D—refractive error	0.000538	0.000538	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTEN—refractive error	0.000523	0.000523	CbGpPWpGaD
Everolimus—MTOR—Disease—PTEN—refractive error	0.000483	0.000483	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP26A1—refractive error	0.000475	0.000475	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTEN—refractive error	0.000338	0.000338	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTEN—refractive error	0.000107	0.000107	CbGpPWpGaD
